EIF2AK4 and pulmonary venoocclusive disease: This identified a novel homozygous pathogenic EIF2AK4 variant c.641delA p.(Lys214Argfs*21) in one family with two affected sisters clinically characterized as HPAH, albeit pulmonary veno-occlusive disease could not be excluded retrospectively.